Pharmacokinetic Aspects of 25-mg Estradiol Pellet in Climacteric Women
Status:
Recruiting
Trial end date:
2024-10-30
Target enrollment:
Participant gender:
Summary
A multicenter, prospective, open-label clinical study will be conducted, to monitor serum
concentration and pharmacokinetic profile after subcutaneous implantation of a 25mg
absorbable pellet containing estradiol in climacteric women.